. 병리결과상 아래와 같이 확인됩니다. Endometrioid carcinoma   - Procedure: total hysterectomy, bilateral salpingo-oophorectomy, pelvic LND and omentectomy   - Tumor site: lower uterine segment  - Tumor size: 10.7x7.5cm   - Histologic type and FIGO grade:       Endometrioid carcinoma, grade 3, with neuroendocrine differentiation   - Depth of invasion (pT2)      - Myometrial invasion: present, one half or more                              (9mm/14mm (myometrial thickness))      - Invades cervical stroma (10mm/19mm (cervical thickness))  - Resection margins: free from carcinoma      (Distance of invasive carcinoma from exocervical margin: 0.3cm)  - Lymph node metastasis: no metastasis in 18 lymph nodes (0/18) (pN0)       Rt.pelvic LN(0/14) Lt.pelvic LN(0/4)   - Lymphovascular Space Invasion: focal(<5), deep myometrial  - Additional findings: Endometrioid intraepithelial neoplasia  - 2023 FIGO staging: IIc------------------------------------------------------------------------ Endometrioid carcinoma, grade 3, with neuroendocrine differentiation  M코드 문의드립니다.  KCD 8차 개정상에는 carcinoma - endometriod - with squamous differentiation 은 있으나 neuroendocrine differentiation은 확인되지 않아 문의드립니다.
M8380/3 (Endometrioid carcinoma)로 코딩하시면 됩니다.